You are here

Safety Alerts, Error Prevention Tips, Patient Safety News Now Available on iPhone Application

January 18, 2010 -- Horsham, Pa.—In cooperation with Brandofino Communications, publisher of Doctor’s Digest, Clinician’s Digest, and Pharmacist’s Digest, the Institute for Safe Medication Practices (ISMP) has launched PracticeRx, a safety alert system and error reporting tool for the iPhone that allows users to access crucial and timely information from the Institute, as well as make a real difference to medication safety by reporting errors.

These users can download the free application in the Medical category using iTunes or their iPhone. Users can report medication errors to ISMP via e-mail on their phone, use the phone to dial ISMP’s 800 number, or send a voice mail created by the application.

ISMP is posting safety alerts and error prevention tips to PracticeRx, as well as patient safety news. A special area has also been devoted to preventing errors with high alert medications, which are more likely to cause serious injuries or death to patients if they are misused.

Users will also receive Practice Management Tips from Doctor's Digest. Tips will be uploaded twice weekly, and are based on cutting-edge information from more than 1,800 thought leaders and experts. Tips are available in text, audio and video formats. Users can also opt-in for a free e-subscription to Doctor's Digest and a personal financial tips e-newsletter for physicians--Doctor's Digest-Money Matters.

Individuals who are not iPhone users can access these offerings via any mobile phone by texting DIGEST to 87415 or by visiting www.doctorsdigest.net.

Source: Institute for Safe Medication Practices

Recent Headlines

Possible First Treatment Option for Rare Autoimmune Disease of the CNS
New Hematologic Biomarker Test Provides New Approach to Sepsis Triage and Diagnosis
Antibiotics, Statins, and Glucocorticoids All Show Promise
Current, Sole Therapy Not Always Successful/Suitable
Over 1.5 Million Americans Likely to have Wet AMD by 2020 
Potential For Use Against E. Coli, TB, Resistant Bacteria
More Than 32% of Patients Responded in Trial
Evenity Increases New Bone Formation, Lowers Vertebral Fracture Potential